JPRN-jRCT1051220093
Recruiting
未知
A study of treatment of cancer cachexia and for reducing side effects of standard cancer treatment with human-derived mesenchymal stem cell conditioned medium
Inami Norihito Norihito0 sites20 target enrollmentSeptember 14, 2022
Overview
- Phase
- 未知
- Intervention
- Not specified
- Conditions
- Cancer cachexia, Side effects of cancer treatment
- Sponsor
- Inami Norihito Norihito
- Enrollment
- 20
- Status
- Recruiting
- Last Updated
- 2 years ago
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- •1\. Patients who want to reduce side effects associated with cancer cachexia and cancer treatment.
- •2\. Patients who have been judged by the doctor to be optimally treated with conditioned medium.
- •Target patients who meet the following criteria.
- •1\. 18 years old and over
- •2\. Have normal consent ability
- •3\. Patients who can obtain their free will consent in writing
- •4\. Patients whose doctor have recognized the need for treatment
Exclusion Criteria
- •Patient who meet any of the following conditions are excluded
- •1\. Have a history of or suspected of dementia
- •2\. Users of narcotics or stimulants
- •3\. Pregnant, breastfeeding
- •4\. Judged unsuitable by the doctor
Outcomes
Primary Outcomes
Not specified
Similar Trials
Completed
Not Applicable
Effect of suppressing the onset of cancer cachexia of Ninjin-yoei-To;Randomized Controlled TrialGastric CancerJPRN-UMIN000043792Osaka Medical and Pharmaceutical College
Completed
Not Applicable
Prospective observational study of cancer-cachexia and its effect on chemotherapy in patients with previously-untreated advanced non-small cell lung cancer (NEJ050A)on-small cell lung cancerJPRN-UMIN000041813orth East Japan Study Group (NEJSG)186
Active, not recruiting
Not Applicable
Treatment of Patients Suffering from Tumour Cachexia with Dronabinol (tetrahydrocannabinol) or PlaceboComparison of individually optimised dosages in a double blind, randomised parallel design - Dronabinol for tumour cachexiaEUCTR2007-002968-10-ATDepartment of Medicine I, Clinical Dep. f. Oncology, University Hospital,74
Active, not recruiting
Not Applicable
Frequency of Cachexia in Ambulatory Cancer Patients and Psychological Burden in Patients and Their Primary CaregiversAdvanced Malignant Solid NeoplasmCaregiverMetastatic Malignant Solid NeoplasmRecurrent LeukemiaRecurrent LymphomaRecurrent Malignant Solid NeoplasmRecurrent Plasma Cell MyelomaNCT04090619M.D. Anderson Cancer Center192
Completed
Phase 3
Multimodal Intervention for Cachexia in Advanced Cancer Patients Undergoing ChemotherapyCachexiaNeoplasmsNCT02330926Norwegian University of Science and Technology221